Astrazeneca says Catalent deal shows importance of in-house

Astrazeneca says Catalent deal shows importance of in-house capacity

Astrazeneca on Thursday said the sale of contract drugmaker Catalent to the parent of Novo Nordisk this week demonstrates the importance of building an independent supply chain....

Related Keywords

Bengaluru , Karnataka , India , London , City Of , United Kingdom , Pascal Soriot , David Goodman , Maggie Fick , Eva Mathews , Novo Nordisk , Astrazeneca , Reuters , Chief Executive Pascal Soriot , Markets ,

© 2025 Vimarsana